Panfeng Tao

638 total citations
15 papers, 226 citations indexed

About

Panfeng Tao is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Panfeng Tao has authored 15 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 3 papers in Genetics. Recurrent topics in Panfeng Tao's work include Ubiquitin and proteasome pathways (4 papers), interferon and immune responses (3 papers) and Identification and Quantification in Food (3 papers). Panfeng Tao is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), interferon and immune responses (3 papers) and Identification and Quantification in Food (3 papers). Panfeng Tao collaborates with scholars based in China, United States and Australia. Panfeng Tao's co-authors include Guosong Zhang, Qing Zhou, Zecheng Li, Pui Y. Lee, Cheng Zhao, Jiawei Chen, Qintao Wang, Xu Han, Zongping Xia and Shihao Wang and has published in prestigious journals such as Nature Communications, Immunity and Journal of Allergy and Clinical Immunology.

In The Last Decade

Panfeng Tao

13 papers receiving 222 citations

Peers

Panfeng Tao
Comparison fields: 5 of 54
  • Immunology 103
  • Molecular Biology 88
  • Ecology 56
  • Cancer Research 56
  • Genetics 31
Replace Jan Staelens with:
Jan Staelens Belgium
Hon-Ren Huang United States
Jessica Weaver United States
Masaru Nonaka Japan
Bernardo R. Peixoto Portugal
Enrique Garcia-Rivera United States
Yile Huang China
Hèléne Fradin United States
Indira Wu United States
Sohye Yoon Australia
Jan Staelens Belgium View profile →
Citations per field, relative to Panfeng Tao
Panfeng Tao · 1×
Citations per year, relative to Panfeng Tao
Panfeng Tao · 1×

Countries citing papers authored by Panfeng Tao

Since Specialization
Citations

This map shows the geographic impact of Panfeng Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panfeng Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panfeng Tao more than expected).

Fields of papers citing papers by Panfeng Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panfeng Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panfeng Tao. The network helps show where Panfeng Tao may publish in the future.

Co-authorship network of co-authors of Panfeng Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Panfeng Tao. A scholar is included among the top collaborators of Panfeng Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panfeng Tao. Panfeng Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
# Work Indexed citations
1 6
2 2
3 4
4 0
5 11
6 38
7 20
8 19
9 1
10 47
11 53
12 8
13 9
14 4
15 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026